MHR
BIIB icon

Matthew Hamilton Rosenberg’s Biogen BIIB Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.91K Hold
35
– – ﹤0.01% 661
2026
Q2 		$7.56K Hold
35
– – ﹤0.01% 658
2026
Q1 		$6.42K Hold
35
– – ﹤0.01% 659
2025
Q4 		$6.16K Hold
35
– – ﹤0.01% 671
2025
Q3 		$4.9K Hold
35
– – ﹤0.01% 695
2025
Q2 		$4.4K Hold
35
– – ﹤0.01% 736
2025
Q1 		$4.79K Hold
35
– – ﹤0.01% 707
2024
Q4 		$5.35K Sell
35
-9
-20% -$1.52K ﹤0.01% 685
2024
Q3 		$8.53K Hold
44
– – ﹤0.01% 644
2024
Q2 		$10.2K Sell
44
-347
-89% -$75.4K ﹤0.01% 588
2024
Q1 		$84K Hold
391
– – 0.02% 342
2023
Q4 		$101K Sell
391
-22
-5% -$5.4K 0.03% 305
2023
Q3 		$106K Hold
413
– – 0.04% 269
2023
Q2 		$118K Sell
413
-72
-15% -$21.4K 0.04% 261
2023
Q1 		$135K Hold
485
– – 0.04% 251
2022
Q4 		$134K Buy
485
+22
+5% +$6.21K 0.05% 255
2022
Q3 		$124K Buy
463
+9
+2% +$1.91K 0.05% 244
2022
Q2 		$96K Buy
454
+345
+317% +$70.5K 0.04% 305
2022
Q1 		$23K Hold
109
– – 0.01% 541
2021
Q4 		$26K Sell
109
-25
-19% -$6.43K 0.01% 496
2021
Q3 		$38K Buy
134
+25
+23% +$8.19K 0.02% 431
2021
Q2 		$38K Hold
109
– – 0.02% 398
2021
Q1 		$30K Sell
109
-28
-20% -$7.55K 0.02% 395
2020
Q4 		$34K Sell
137
-45
-25% -$11.6K 0.02% 369
2020
Q3 		$52K Sell
182
-81
-31% -$22.6K 0.04% 300
2020
Q2 		$70K Sell
263
-100
-28% -$30.1K 0.06% 251
2020
Q1 		$115K Buy
+363
New +$110K 0.11% 102

Other funds holding BIIB

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TF
Tompkins Financial Ithaca, New York $1.42B AUM 19.14% 1-Year Est. Return
BCM
Boltwood Capital Management Walnut Creek, California $443M AUM 17.72% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return

Matthew Hamilton Rosenberg's BIIB Position: Q3 2026 in Review

Matthew Hamilton Rosenberg held its Biogen (BIIB) position steady in Q3 2026 at 35 shares worth $7.91K. The position accounts for ﹤0.01% of the portfolio, ranked #661.

Matthew Hamilton Rosenberg first reported a position in BIIB in Q1 2020 and has held it in 27 quarters since. The position peaked at $135K in Q1 2023. 31 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Matthew Hamilton Rosenberg held 35 shares of Biogen worth $7.91K as of Q3 2026.
  • Matthew Hamilton Rosenberg left its Biogen share count unchanged in Q3 2026.
  • Biogen made up ﹤0.01% of Matthew Hamilton Rosenberg's portfolio in Q3 2026, its #661 holding.
  • Matthew Hamilton Rosenberg first reported a position in Biogen in Q1 2020 and has held it in 27 quarters since.
  • Matthew Hamilton Rosenberg's Biogen position peaked at $135K in Q1 2023.
  • 31 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q3 2026, filed 5 Oct 2026.